Genvax
Ames, US · 2 known investors
Genvax Technologies develops mRNA and nanoparticle-based vaccines for livestock, focusing on custom, herd-specific formulations that aim to improve speed and precision compared to conventional vaccine platforms. The company serves animal health and food supply sectors.
Founders & leadership
JH
Joel HarrisinCo-founder
DH
Dr. Hank HarrisCo-founder
DH
DL Hank HarrisDirector
SH
Scott HolmstromDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$3.4MraisedJun 2024 · 9 investors · OtherRule 506(b)
▶$3.4MraisedJun 2024 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Joel HarrisExecutive Officer, Director
- Trent TorranceDirector
- DL Hank HarrisDirector
- Offering amount
- $5.2M
- Amount sold
- $3.4M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$6.4MraisedAug 2022 · 20 investors · OtherRule 506(b)
▶$6.4MraisedAug 2022 · 20 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- DL Hank HarrisDirector
- Scott HolmstromDirector
- Joel HarrisExecutive Officer, Director
- Offering amount
- $6.4M
- Amount sold
- $6.4M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.